Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own SWTX please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-16 10:25 AM EDT
Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 3, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Relmada Therapeutics, Inc. (NASDAQ: RLMD) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own RLMD please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-03 3:30 PM EDT
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 3, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own ZNTL please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-03 10:48 AM EDT
Kuehn Law Encourages Long-Term Investors of Celularity Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - April 22, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Celularity, Inc. (NASDAQ: CELU) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own CELU and purchase BEFORE June 2022 please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833)...
2024-04-22 1:46 PM EDT
Kuehn Law Encourages Investors of Ginkgo Bioworks Holdings, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 15, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own DNA please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-03-15 12:54 PM EDT
Kuehn Law Encourages Investors of ImmunityBio, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 15, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of ImmunityBio, Inc. (NASDAQ: IBRX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own IBRX please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The consultation and...
2024-03-15 12:51 PM EDT
Kuehn Law Encourages Investors of Guardant Health, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 15, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Guardant Health, Inc. (NASDAQ: GH) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own GH please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The consultation and...
2024-03-15 12:46 PM EDT
Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 15, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Ultragenyx Pharmaceutical, Inc. (NASDAQ: RARE) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own RARE please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-03-15 12:43 PM EDT
Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 15, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Intellia Therapeutics, Inc. (NASDAQ: NTLA) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own NTLA please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-03-15 12:40 PM EDT
Kuehn Law Encourages Investors of Regeneron Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 14, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own REGN please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-03-14 2:40 PM EDT
Kuehn Law Encourages Investors of Celularity Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 14, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Celularity, Inc. (NASDAQ: CELU) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own CELU please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The consultation and...
2024-03-14 2:39 PM EDT
Kuehn Law Encourages Investors of Relay Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 14, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Relay Therapeutics, Inc. (NASDAQ: RLAY) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own RLAY please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-03-14 2:00 PM EDT
Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 14, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own SWTX please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-03-14 1:52 PM EDT
Kuehn Law Encourages Investors of Apellis Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - February 15, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Apellis insiders caused the company to misrepresent or fail to disclose that (1) the design of SYFOVRE's clinical trials was insufficient to identify incidents of retinal vasculitis in...
2024-02-15 5:40 PM EST
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - February 15, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Amylyx insiders caused the company to misrepresent or fail to disclose that (i) RELYVRIO's commercial prospects were overstated; (ii) patients were discontinuing treatment with RELYVRIO after...
2024-02-15 5:31 PM EST
Kuehn Law Encourages Investors of Roblox Corporation to Contact Law Firm
New York, New York--(Newsfile Corp. - February 5, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Roblox Corporation (NYSE: RBLX) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Roblox insiders caused the company to misrepresent or fail to disclose that (1) the Roblox platform suffered from a lack of adequate content filters and did not impose limits on user expenditures; (2)...
2024-02-05 10:29 AM EST
Kuehn Law Encourages Investors of DocGo, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - February 2, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DocGo, Inc. (NASDAQ: DCGO) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, DocGo insiders caused the company to misrepresent or fail to disclose that (i) the processes DocGo used to hire executives were insufficient for thoroughly examining and verifying the professional and...
2024-02-02 5:58 PM EST
Kuehn Law Encourages Investors of LivePerson, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - February 2, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of LivePerson, Inc. (NASDAQ: LPSN) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, LivePerson insiders caused the company to (i) maintain a significant deficiency in its disclosure controls and procedures; (ii) as a consequence, LivePerson's internal controls over financial reporting...
2024-02-02 5:15 PM EST
Kuehn Law Encourages Investors of Charge Enterprises, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - February 1, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Charge Enterprises, Inc. (NASDAQ: CRGE) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own CRGE please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-02-01 10:47 PM EST
Moore Kuehn, PLLC Encourages Investors of HighPeak Energy, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - October 3, 2023) - Moore Kuehn, PLLC, a securities law firm located on Wall Street , is investigating whether certain officers and directors of HighPeak Energy, Inc. (NASDAQ: HPK) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own HPK please contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com or telephone at (212)...
2023-10-03 11:29 AM EDT